GSK620

CAS No. 2088410-46-0

GSK620 ( —— )

Catalog No. M23936 CAS No. 2088410-46-0

GSK620 is a pan-BD2 inhibitor, which shows an anti-inflammatory phenotype in human whole blood with excellent broad selectivity, developability, and in vivo oral pharmacokinetics.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 68 In Stock
10MG 110 In Stock
25MG 222 In Stock
50MG 356 In Stock
100MG 530 In Stock
500MG 1152 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK620
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK620 is a pan-BD2 inhibitor, which shows an anti-inflammatory phenotype in human whole blood with excellent broad selectivity, developability, and in vivo oral pharmacokinetics.
  • Description
    GSK620 is a pan-BD2 inhibitor, which shows an anti-inflammatory phenotype in human whole blood with excellent broad selectivity, developability, and in vivo oral pharmacokinetics.GSK620 is highly selective for the BET-BD2 family of proteins, with >200-fold selectivity over all other bromodomains. GSK620 shows an anti-inflammatory phenotype in human whole blood.
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    pan-BD2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2088410-46-0
  • Formula Weight
    325.4
  • Molecular Formula
    C18H19N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:62.5 mg/mL (192.09 mM; Need ultrasonic)
  • SMILES
    CNC(=O)C1=CC(=CN(C1=O)CC2=CC=CC=C2)C(=O)NC3CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Seal JT, et al. The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor. J Med Chem. 2020;63(17):9093-9126.
molnova catalog
related products
  • 2-methyl-2,3,4,5-tet...

    2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.

  • dCBP-1

    dCBP-1 is a chemical degrader of p300/CBP. dCBP-1 hijacks the E3 ubiquitin ligase CRBN for selective degradation of p300/CBP. Degradation of p300/CBP by dCBP-1 leads to effective multiple myeloma cell killing.

  • Cyclogalegenol

    Astramembrangenin (Cycloastragenol) is a triterpenoid saponin compound and a hydrolysis product of the main active ingredient in Astragalus membranaceus.?Cycloastragenol (CAG) may have a novel therapeutic role in depression.